Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases A Undas, RAS Ariëns Arteriosclerosis, thrombosis, and vascular biology 31 (12), e88-e99, 2011 | 576 | 2011 |
Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms RAS Ariëns, TS Lai, JW Weisel, CS Greenberg, PJ Grant Blood, The Journal of the American Society of Hematology 100 (3), 743-754, 2002 | 489 | 2002 |
The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure RAS Ariëns, H Philippou, C Nagaswami, JW Weisel, DA Lane, PJ Grant Blood, The Journal of the American Society of Hematology 96 (3), 988-995, 2000 | 451 | 2000 |
Tissue-factor antigen and activity in human coronary atherosclerotic plaques D Ardissino, PA Merlini, R Ariëns, R Coppola, E Bramucci, PM Mannucci The Lancet 349 (9054), 769-771, 1997 | 365 | 1997 |
The genetics of haemostasis: a twin study M de Lange, H Snieder, RAS Ariëns, TD Spector, PJ Grant The Lancet 357 (9250), 101-105, 2001 | 347 | 2001 |
The influence of type 2 diabetes on fibrin structure and function EJ Dunn, RAS Ariëns, PJ Grant Diabetologia 48, 1198-1206, 2005 | 285 | 2005 |
Thrombus composition and efficacy of thrombolysis and thrombectomy in acute ischemic stroke P Jolugbo, RAS Ariëns Stroke 52 (3), 1131-1142, 2021 | 256 | 2021 |
Bleeding and thrombotic complications in the use of extracorporeal membrane oxygenation J Thomas, V Kostousov, J Teruya Seminars in thrombosis and hemostasis 44 (01), 020-029, 2018 | 253 | 2018 |
Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk BCB Lim, RAS Ariëns, AM Carter, JW Weisel, PJ Grant The Lancet 361 (9367), 1424-1431, 2003 | 246 | 2003 |
Diagnosis and classification of factor XIII deficiencies HP Kohler, A Ichinose, R Seitz, RAS Ariens, L Muszbek, ONBOFTHEF XIII, ... Journal of Thrombosis and Haemostasis 9 (7), 1404-1406, 2011 | 229 | 2011 |
Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease JD Mills, RAS Ariëns, MW Mansfield, PJ Grant Circulation 106 (15), 1938-1942, 2002 | 227 | 2002 |
Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus EJ Dunn, H Philippou, RAS Ariëns, PJ Grant Diabetologia 49, 1071-1080, 2006 | 213 | 2006 |
The molecular physiology and pathology of fibrin structure/function KF Standeven, RAS Ariëns, PJ Grant Blood reviews 19 (5), 275-288, 2005 | 212 | 2005 |
The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis EL Hethershaw, ALC La Corte, C Duval, M Ali, PJ Grant, RAS Ariëns, ... Journal of Thrombosis and Haemostasis 12 (2), 197-205, 2014 | 202 | 2014 |
Fibrin (ogen) and thrombotic disease RAS Ariëns Journal of Thrombosis and Haemostasis 11, 294-305, 2013 | 192 | 2013 |
Atomic force microscopy-based molecular recognition of a fibrinogen receptor on human erythrocytes FA Carvalho, S Connell, G Miltenberger-Miltenyi, SV Pereira, A Tavares, ... ACS nano 4 (8), 4609-4620, 2010 | 190 | 2010 |
Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease EM Scott, RAS Ariëns, PJ Grant Arteriosclerosis, thrombosis, and vascular biology 24 (9), 1558-1566, 2004 | 189 | 2004 |
Functional analysis of the fibrinogen Aα Thr312Ala polymorphism: effects on fibrin structure and function KF Standeven, PJ Grant, AM Carter, T Scheiner, JW Weisel, RAS Ariëns Circulation 107 (18), 2326-2330, 2003 | 171 | 2003 |
Fibrinogen gamma-chain splice variant γ′ alters fibrin formation and structure AV Cooper, KF Standeven, RAS Ariëns Blood 102 (2), 535-540, 2003 | 165 | 2003 |
International registry on factor XIII deficiency: a basis formed mostly on European data V Ivaskevicius, R Seitz, HP Kohler, V Schroeder, L Muszbek, RAS Ariens, ... Thrombosis and haemostasis 97 (06), 914-921, 2007 | 164 | 2007 |